Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

The impact of COVID-19 on chronic disease management and the implications for pharma marketing

The impact of COVID-19 on chronic disease management and the implications for pharma marketing

On February 11, 2020, COVID-19 was officially named by the World Health Organisation (WHO). Since then the novel coronavirus causing it, (a severe acute respiratory syndrome) has left its mark on almost every country in the world.

Therapy Watch, our syndicated PRF tracker, has been investigating the impact of COVID-19 on chronic disease management. In this white paper, we share some of the insights and consider future impact.

read more »

  • Posted by George Forsyth
  • July 27, 2020
  • Articles

How will COVID-19 affect the financing of healthcare provision across the US?

How will COVID-19 affect the financing of healthcare provision across the US?

Using findings from our syndicated study to assess the impact of COVID-19 on biopharmaceutical market access, Senior Consultant George Forsyth explores the economic impact to the US healthcare system. Published by Pharma Exec in June 2020.

The current coronavirus pandemic sweeping across the globe represents one of the greatest fiscal challenges to US healthcare policymakers in modern times. The Federal Reserve expects the US economy to contract by a staggering 6.5% this year, with approximately 20 million Americans unemployed and many more without medical insurance. 

read more »

How we helped our client maximise uptake and fine-tune the marketing strategy for their vaccine product in China

How we helped our client maximise uptake and fine-tune the marketing strategy for their vaccine product in China

Our client’s vaccine to protect against a condition prevalent in older adults had recently launched and secondary research was required to enable them to understand more about their target healthcare consumer and attitudes to health, well-being and vaccination. They needed to build a complete picture of how consumers are influenced, such as whether they are more influenced by HCP advice or online forums and social media. Furthermore they needed to develop an understanding for other out-of-pocket (OOP) competitor vaccines and what the future healthcare initiatives mean for vaccination in general.
 

read more »

  • Posted by Dan Coffin
  • July 24, 2020
  • Articles

What’s next? How behavioural science can support pharma’s future

What’s next? How behavioural science can support pharma’s future

Dan Coffin, Director explains why now is an opportune time for pharma marketers to embrace behavioural science. Published in PME Magazine, July 2020.

A marketer’s goal is to encourage customers to change their behaviour and adopt the brand. It can be a tough challenge. Yet the pandemic has required billions of people to change their behaviour in the blink of an eye. The reality is that customers have never been so open to change. For pharma marketers, understanding and shaping these changing behaviours could be key to differentiating and optimising their brand potential. This is an opportune time to embrace behavioural science which, in recent years, has been successfully adopted and used by government and private enterprise as a means to enable favourable behaviours that benefit brands. It’s essentially about tapping into the unconscious biases and heuristics we each unknowingly hold when making decisions. If we can understand these biases at play, then we can provide nudges to effect a positive change in behaviour.

read more »

  • Posted by Liza Pliss
  • July 24, 2020
  • Videos

UX/ Experience design research

Director and UX expert Liza Pliss discusses our approach to user experience research and shares an example of a project where using design thinking led to an agile approach focused on iteration.

read more »